Effects of low-molecular weight and high-molecular weight heparin on the intrinsic and extrinsic endogenous fibrinolytic system

[1]  H. Anderson,et al.  Thrombolysis in acute myocardial infarction. , 1993, The New England journal of medicine.

[2]  P. Eisenberg.  Role of heparin in coronary thrombolysis. , 1992, Chest.

[3]  W. Daniel,et al.  Increased Thrombin Levels During Thrombolytic Therapy in Acute Myocardial Infarction: Relevance for the Success of Therapy , 1991, Circulation.

[4]  N. Marsh.  Annotation * DOES HEPARIN STIMULATE FIBRINOLYSIS? , 1990 .

[5]  P. Klein.  Plasma levels of t-PA:Ag under standard heparin therapy. , 1989, Thrombosis research.

[6]  G. Fuhrer,et al.  Studies on the inhibition of plasma kallikrein, C1-esterase and beta-FXIIa in the presence and the absence of heparins. , 1989, Advances in experimental medicine and biology.

[7]  K. Mann,et al.  Activation/inactivation of human factor V by plasmin. , 1989, Blood.

[8]  W. Daniel,et al.  Potentiation of the Thrombolytic Efficacy of Single-Chain Urokinase (Pro-Urokinase) by Heparin , 1988, Thrombosis and Haemostasis.

[9]  J. T. ten Cate,et al.  Effects of Standard Heparin and a Low Molecular Weight Heparin (Kabi 2165) on Fibrinolysis , 1988, Thrombosis and Haemostasis.

[10]  H. Verspaget,et al.  Plasminogen activator profiles in neoplastic tissues of the human colon. , 1988, Cancer research.

[11]  Sol Sherry,et al.  Thrombolytic Therapy: Current Status , 1988 .

[12]  G. FitzGerald,et al.  Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. , 1988, Circulation.

[13]  A. Jaffe,et al.  Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. , 1987, Journal of the American College of Cardiology.

[14]  W. Rees,et al.  A direct cbromogenic peptide substrate assay for hageman factor (FXII) , 1987 .

[15]  H. Hod,et al.  Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin. , 1986, Circulation.

[16]  M. Verstraete,et al.  Effect of Standard and Low-Molecular Weight Heparin Fractions on Fibrinolysis and Platelet Aggregation in Patients Undergoing Hysterectomy , 1986, Thrombosis and Haemostasis.

[17]  Gallimore Mj.  Chromogenic peptide substrate assays for determining components of the plasma kallikrein system. , 1985 .

[18]  H. Vinazzer,et al.  Influence of heparin; of different heparin fractions and of a low molecular weight heparin-like substance on the mechanism of fibrinolysis. , 1982, Thrombosis research.

[19]  M. Gallimore,et al.  Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. , 1982, Thrombosis research.

[20]  H. Zimmermann,et al.  Model building and testing for the change‐over design , 1980 .